CLINICAL_TRIALS
trial_result
· 2019-06-28
Clinical Trial Update: Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study
Summary
A real-life study evaluating the biosimilar Nivestim® for preventing chemotherapy-induced neutropenia; the trial has been terminated with results posted in 2019…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Chemotherapy-Induced Neutropenia | Status: TERMINATED | Results posted: 2019-06-28